
### [MONDO:0002242](http://purl.obolibrary.org/obo/MONDO_0002242)
**Label:** coagulation protein disease

**Subclasses:** [MONDO:0013331](http://purl.obolibrary.org/obo/MONDO_0013331) (factor 5 and Factor Viii, combined deficiency of, 2), [MONDO:0015631](http://purl.obolibrary.org/obo/MONDO_0015631) (von willebrand disease type 2N), [MONDO:0015630](http://purl.obolibrary.org/obo/MONDO_0015630) (von willebrand disease type 2M), [MONDO:0018029](http://purl.obolibrary.org/obo/MONDO_0018029) (congenital factor XIII deficiency), [MONDO:0010187](http://purl.obolibrary.org/obo/MONDO_0010187) (vitamin K-dependent clotting factors, combined deficiency of, type 1), [MONDO:0019039](http://purl.obolibrary.org/obo/MONDO_0019039) (rare hemorrhagic disorder due to a constitutional coagulation factors defect), [MONDO:0009234](http://purl.obolibrary.org/obo/MONDO_0009234) (congenital high-molecular-weight kininogen deficiency), [MONDO:0018660](http://purl.obolibrary.org/obo/MONDO_0018660) (hemophilia), [MONDO:0009315](http://purl.obolibrary.org/obo/MONDO_0009315) (congenital factor XII deficiency), [MONDO:0008668](http://purl.obolibrary.org/obo/MONDO_0008668) (von willebrand's disease 1), [MONDO:0018060](http://purl.obolibrary.org/obo/MONDO_0018060) (congenital fibrinogen deficiency), [MONDO:0011837](http://purl.obolibrary.org/obo/MONDO_0011837) (vitamin K-dependent clotting factors, combined deficiency of, type 2), [MONDO:0020460](http://purl.obolibrary.org/obo/MONDO_0020460) (acquired von willebrand syndrome), [MONDO:0015719](http://purl.obolibrary.org/obo/MONDO_0015719) (severe hemophilia A), [MONDO:0015716](http://purl.obolibrary.org/obo/MONDO_0015716) (Moderately severe hemophilia b), [MONDO:0015715](http://purl.obolibrary.org/obo/MONDO_0015715) (severe hemophilia b), [MONDO:0015717](http://purl.obolibrary.org/obo/MONDO_0015717) (mild hemophilia b), [MONDO:0013775](http://purl.obolibrary.org/obo/MONDO_0013775) (thrombomodulin-related bleeding disorder), [MONDO:0015787](http://purl.obolibrary.org/obo/MONDO_0015787) (symptomatic form of hemophilia a in female carriers), [MONDO:0016990](http://purl.obolibrary.org/obo/MONDO_0016990) (acquired prothrombin deficiency), [MONDO:0013361](http://purl.obolibrary.org/obo/MONDO_0013361) (prothrombin deficiency), [MONDO:0010097](http://purl.obolibrary.org/obo/MONDO_0010097) (Tatsumi factor deficiency), [MONDO:0014452](http://purl.obolibrary.org/obo/MONDO_0014452) (familial dysfibrinogenemia), [MONDO:0008332](http://purl.obolibrary.org/obo/MONDO_0008332) (platelet-type bleeding disorder 3), [MONDO:0018175](http://purl.obolibrary.org/obo/MONDO_0018175) (combined deficiency of factor V and factor VIII), [MONDO:0002247](http://purl.obolibrary.org/obo/MONDO_0002247) (factor X deficiency), [MONDO:0008737](http://purl.obolibrary.org/obo/MONDO_0008737) (congenital afibrinogenemia), [MONDO:0002244](http://purl.obolibrary.org/obo/MONDO_0002244) (factor VII deficiency), [MONDO:0000184](http://purl.obolibrary.org/obo/MONDO_0000184) (congenital vitamin K-dependent coagulation factors combined deficiency), [MONDO:0002241](http://purl.obolibrary.org/obo/MONDO_0002241) (factor XIII deficiency), [MONDO:0015628](http://purl.obolibrary.org/obo/MONDO_0015628) (von willebrand disease type 2A), [MONDO:0015629](http://purl.obolibrary.org/obo/MONDO_0015629) (von willebrand disease type 2B), [MONDO:0015788](http://purl.obolibrary.org/obo/MONDO_0015788) (symptomatic form of hemophilia b in female carriers), [MONDO:0016638](http://purl.obolibrary.org/obo/MONDO_0016638) (familial hypodysfibrinogenemia), [MONDO:0019139](http://purl.obolibrary.org/obo/MONDO_0019139) (acquired hemophilia), [MONDO:0008560](http://purl.obolibrary.org/obo/MONDO_0008560) (thrombophilia due to activated protein C resistance), [MONDO:0009210](http://purl.obolibrary.org/obo/MONDO_0009210) (congenital factor V deficiency), [MONDO:0009211](http://purl.obolibrary.org/obo/MONDO_0009211) (congenital factor VII deficiency), [MONDO:0009212](http://purl.obolibrary.org/obo/MONDO_0009212) (congenital factor X deficiency), [MONDO:0021134](http://purl.obolibrary.org/obo/MONDO_0021134) (acquired factor X deficiency), [MONDO:0015096](http://purl.obolibrary.org/obo/MONDO_0015096) (familial hypofibrinogenemia), [MONDO:0013190](http://purl.obolibrary.org/obo/MONDO_0013190) (factor Xiii, b subunit, deficiency of), [MONDO:0010604](http://purl.obolibrary.org/obo/MONDO_0010604) (hemophilia B), [MONDO:0007622](http://purl.obolibrary.org/obo/MONDO_0007622) (Flood factor deficiency), [MONDO:0021133](http://purl.obolibrary.org/obo/MONDO_0021133) (acquired factor XIII deficiency), [MONDO:0010602](http://purl.obolibrary.org/obo/MONDO_0010602) (hemophilia A), [MONDO:0011615](http://purl.obolibrary.org/obo/MONDO_0011615) (East Texas bleeding disorder), [MONDO:0010603](http://purl.obolibrary.org/obo/MONDO_0010603) (hemophilia A with vascular abnormality), [MONDO:0012901](http://purl.obolibrary.org/obo/MONDO_0012901) (congenital prekallikrein deficiency), [MONDO:0017837](http://purl.obolibrary.org/obo/MONDO_0017837) (multiple sclerosis-ichthyosis-factor VIII deficiency syndrome), [MONDO:0015721](http://purl.obolibrary.org/obo/MONDO_0015721) (mild hemophilia A), [MONDO:0015720](http://purl.obolibrary.org/obo/MONDO_0015720) (moderately severe hemophilia A), [MONDO:0009883](http://purl.obolibrary.org/obo/MONDO_0009883) (alpha-2-plasmin inhibitor deficiency), [MONDO:0013187](http://purl.obolibrary.org/obo/MONDO_0013187) (factor Xiii, a subunit, deficiency of), [MONDO:0019565](http://purl.obolibrary.org/obo/MONDO_0019565) (von willebrand disease), [MONDO:0009206](http://purl.obolibrary.org/obo/MONDO_0009206) (factor v and Factor VIII, combined deficiency of, type 1), [MONDO:0009207](http://purl.obolibrary.org/obo/MONDO_0009207) (factor v and Factor VIII, combined deficiency of, with normal protein c and Protein C inhibitor), [MONDO:0009009](http://purl.obolibrary.org/obo/MONDO_0009009) (hypoplasminogenemia), [MONDO:0010191](http://purl.obolibrary.org/obo/MONDO_0010191) (von Willebrand's disease 3), [MONDO:0012897](http://purl.obolibrary.org/obo/MONDO_0012897) (congenital factor XI deficiency), [MONDO:0010756](http://purl.obolibrary.org/obo/MONDO_0010756) (Von Willebrand disease, X-linked form), [MONDO:0015722](http://purl.obolibrary.org/obo/MONDO_0015722) (congenital vitamin K-dependent coagulation factors deficiency), [MONDO:0013304](http://purl.obolibrary.org/obo/MONDO_0013304) (von willebrand's disease 2), [MONDO:0013227](http://purl.obolibrary.org/obo/MONDO_0013227) (congenital plasminogen activator inhibitor type 1 deficiency), [MONDO:0015801](http://purl.obolibrary.org/obo/MONDO_0015801) (hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation), 

**Mapped go classes:** [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0090331](http://purl.obolibrary.org/obo/GO_0090331) (negative regulation of platelet aggregation), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0045765](http://purl.obolibrary.org/obo/GO_0045765) (regulation of angiogenesis), [GO:1904854](http://purl.obolibrary.org/obo/GO_1904854) (proteasome core complex binding), [GO:0052182](http://purl.obolibrary.org/obo/GO_0052182) (modification by host of symbiont morphology or physiology via secreted substance), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0043623](http://purl.obolibrary.org/obo/GO_0043623) (cellular protein complex assembly), [GO:0045921](http://purl.obolibrary.org/obo/GO_0045921) (positive regulation of exocytosis), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0052213](http://purl.obolibrary.org/obo/GO_0052213) (interaction with symbiont via secreted substance involved in symbiotic interaction), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding), [GO:0010812](http://purl.obolibrary.org/obo/GO_0010812) (negative regulation of cell-substrate adhesion), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031639](http://purl.obolibrary.org/obo/GO_0031639) (plasminogen activation), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0017187](http://purl.obolibrary.org/obo/GO_0017187) (peptidyl-glutamic acid carboxylation), [GO:1990405](http://purl.obolibrary.org/obo/GO_1990405) (protein antigen binding), [GO:0050714](http://purl.obolibrary.org/obo/GO_0050714) (positive regulation of protein secretion), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0031232](http://purl.obolibrary.org/obo/GO_0031232) (extrinsic component of external side of plasma membrane), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body), [GO:2000098](http://purl.obolibrary.org/obo/GO_2000098) (negative regulation of smooth muscle cell-matrix adhesion), [GO:0061044](http://purl.obolibrary.org/obo/GO_0061044) (negative regulation of vascular wound healing), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0007029](http://purl.obolibrary.org/obo/GO_0007029) (endoplasmic reticulum organization), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0051258](http://purl.obolibrary.org/obo/GO_0051258) (protein polymerization), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0031589](http://purl.obolibrary.org/obo/GO_0031589) (cell-substrate adhesion), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0030017](http://purl.obolibrary.org/obo/GO_0030017) (sarcomere), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0090277](http://purl.obolibrary.org/obo/GO_0090277) (positive regulation of peptide hormone secretion), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0044218](http://purl.obolibrary.org/obo/GO_0044218) (other organism cell membrane), [GO:0005577](http://purl.obolibrary.org/obo/GO_0005577) (fibrinogen complex), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0010757](http://purl.obolibrary.org/obo/GO_0010757) (negative regulation of plasminogen activation), [GO:0071674](http://purl.obolibrary.org/obo/GO_0071674) (mononuclear cell migration), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0047057](http://purl.obolibrary.org/obo/GO_0047057) (vitamin-K-epoxide reductase (warfarin-sensitive) activity), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0010638](http://purl.obolibrary.org/obo/GO_0010638) (positive regulation of organelle organization), [GO:0044220](http://purl.obolibrary.org/obo/GO_0044220) (host cell perinuclear region of cytoplasm), [GO:0051549](http://purl.obolibrary.org/obo/GO_0051549) (positive regulation of keratinocyte migration), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0051702](http://purl.obolibrary.org/obo/GO_0051702) (interaction with symbiont), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0035491](http://purl.obolibrary.org/obo/GO_0035491) (positive regulation of leukotriene production involved in inflammatory response), [GO:0022617](http://purl.obolibrary.org/obo/GO_0022617) (extracellular matrix disassembly), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0006953](http://purl.obolibrary.org/obo/GO_0006953) (acute-phase response), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0006825](http://purl.obolibrary.org/obo/GO_0006825) (copper ion transport), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0030194](http://purl.obolibrary.org/obo/GO_0030194) (positive regulation of blood coagulation), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0045445](http://purl.obolibrary.org/obo/GO_0045445) (myoblast differentiation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0019842](http://purl.obolibrary.org/obo/GO_0019842) (vitamin binding), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0090026](http://purl.obolibrary.org/obo/GO_0090026) (positive regulation of monocyte chemotaxis), [GO:0042583](http://purl.obolibrary.org/obo/GO_0042583) (chromaffin granule), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0003810](http://purl.obolibrary.org/obo/GO_0003810) (protein-glutamine gamma-glutamyltransferase activity), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0072378](http://purl.obolibrary.org/obo/GO_0072378) (blood coagulation, fibrin clot formation), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0010469](http://purl.obolibrary.org/obo/GO_0010469) (regulation of receptor activity), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0030173](http://purl.obolibrary.org/obo/GO_0030173) (integral component of Golgi membrane), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0008488](http://purl.obolibrary.org/obo/GO_0008488) (gamma-glutamyl carboxylase activity), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0004322](http://purl.obolibrary.org/obo/GO_0004322) (ferroxidase activity), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:0014912](http://purl.obolibrary.org/obo/GO_0014912) (negative regulation of smooth muscle cell migration), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0071636](http://purl.obolibrary.org/obo/GO_0071636) (positive regulation of transforming growth factor beta production), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0031091](http://purl.obolibrary.org/obo/GO_0031091) (platelet alpha granule), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0051918](http://purl.obolibrary.org/obo/GO_0051918) (negative regulation of fibrinolysis), [GO:0050829](http://purl.obolibrary.org/obo/GO_0050829) (defense response to Gram-negative bacterium), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0051919](http://purl.obolibrary.org/obo/GO_0051919) (positive regulation of fibrinolysis), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0002034](http://purl.obolibrary.org/obo/GO_0002034) (regulation of blood vessel diameter by renin-angiotensin), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0005537](http://purl.obolibrary.org/obo/GO_0005537) (mannose binding), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034116](http://purl.obolibrary.org/obo/GO_0034116) (positive regulation of heterotypic cell-cell adhesion), [GO:0071347](http://purl.obolibrary.org/obo/GO_0071347) (cellular response to interleukin-1), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0019897](http://purl.obolibrary.org/obo/GO_0019897) (extrinsic component of plasma membrane), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0050820](http://purl.obolibrary.org/obo/GO_0050820) (positive regulation of coagulation), 

**Class expressions from DL-Learner:**

- Thing 54.95%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.83%
- [GO:0044220](http://purl.obolibrary.org/obo/GO_0044220) (host cell perinuclear region of cytoplasm) 50.83%
- [GO:0042583](http://purl.obolibrary.org/obo/GO_0042583) (chromaffin granule) 50.83%
- [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body) 50.83%
- [GO:0031091](http://purl.obolibrary.org/obo/GO_0031091) (platelet alpha granule) 50.83%
- [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle) 50.83%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 50.83%
- [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment) 50.83%
- [GO:0030136](http://purl.obolibrary.org/obo/GO_0030136) (clathrin-coated vesicle) and [GO:0099503](http://purl.obolibrary.org/obo/GO_0099503) (secretory vesicle) 50.83%
- [GO:0030136](http://purl.obolibrary.org/obo/GO_0030136) (clathrin-coated vesicle) and [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule) 50.83%
- [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle) and [GO:0099503](http://purl.obolibrary.org/obo/GO_0099503) (secretory vesicle) 50.83%
- [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle) and [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule) 50.83%
- [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle) 42.49%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.19%


